Kerna
Kerna Labs
United States · Founded 2024
- Employees
- 1–10
- Founded
- 2024
- Website
- kernalabs.ai
- Last Round
- SeedJan 2025
- Rounds
- 1
About
Kerna Labs is building a foundation model for mRNA therapeutics, using AI and high-throughput biology to decode RNA biology and unlock mRNA's potential as a universal toolkit for genetic medicine. Its platform designs mRNA sequences with customizable expression profiles, cell-type specific targeting, and enhanced half-life for higher protein output. Founded in 2024 by CEO Julia Peng, CTO Amit Deshwar, and Melissa J. Moore (former Moderna CSO), the Bay Area biotech closed an oversubscribed seed round in early 2025.
Summary
Kerna is a Biotech company based in United States, founded in 2024. Its most recent funding was a Seed round in Jan 2025. Investors include Gradient Ventures, Humba Ventures and TAU Ventures.
Tech & App Stack
1 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2025
Investors
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/kerna"><img src="https://indexed.vc/api/badge/company/kerna" alt="Kerna on Indexed.vc" width="260" height="76" /></a>